Keywords: Ipsen, First-quarter 2010 results
France’s Ipsen sees first quarter 2010 sales rise 5.7%
Article | 05 May 2010
French drugmaker Ipsen reports that consolidated group sales for the first quarter of 2010 reached 266.2 million euros ($354 million), up 5.7% year-on-year. Of ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
- Additional indications in Japan for Roche's Avastin and Astellas' Prograf
- US Supreme Court says patent settlement can "sometimes" be illegal
